JP2023538901A5 - - Google Patents

Info

Publication number
JP2023538901A5
JP2023538901A5 JP2023511830A JP2023511830A JP2023538901A5 JP 2023538901 A5 JP2023538901 A5 JP 2023538901A5 JP 2023511830 A JP2023511830 A JP 2023511830A JP 2023511830 A JP2023511830 A JP 2023511830A JP 2023538901 A5 JP2023538901 A5 JP 2023538901A5
Authority
JP
Japan
Prior art keywords
polymer
ketamine
microsphere
polymer microspheres
lactide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023511830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538901A (ja
JP7814375B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/046220 external-priority patent/WO2022040130A1/en
Publication of JP2023538901A publication Critical patent/JP2023538901A/ja
Publication of JP2023538901A5 publication Critical patent/JP2023538901A5/ja
Application granted granted Critical
Publication of JP7814375B2 publication Critical patent/JP7814375B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023511830A 2020-08-18 2021-08-17 ケタミンを含むマイクロスフェア製剤ならびにその製造及び使用方法 Active JP7814375B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063067068P 2020-08-18 2020-08-18
US63/067,068 2020-08-18
US202163149911P 2021-02-16 2021-02-16
US63/149,911 2021-02-16
PCT/US2021/046220 WO2022040130A1 (en) 2020-08-18 2021-08-17 Microsphere formulations comprising ketamine and methods for making and using the same

Publications (3)

Publication Number Publication Date
JP2023538901A JP2023538901A (ja) 2023-09-12
JP2023538901A5 true JP2023538901A5 (https=) 2024-08-15
JP7814375B2 JP7814375B2 (ja) 2026-02-16

Family

ID=80270269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023511830A Active JP7814375B2 (ja) 2020-08-18 2021-08-17 ケタミンを含むマイクロスフェア製剤ならびにその製造及び使用方法

Country Status (10)

Country Link
US (1) US12233165B2 (https=)
EP (1) EP4199917B1 (https=)
JP (1) JP7814375B2 (https=)
KR (1) KR20230052915A (https=)
CN (1) CN115942935B (https=)
AU (1) AU2021329820A1 (https=)
CA (1) CA3191160A1 (https=)
IL (1) IL300547A (https=)
TW (1) TWI906350B (https=)
WO (1) WO2022040130A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2907692T3 (es) 2017-12-29 2022-04-26 Celon Pharma Sa Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento
EP4611729A1 (en) * 2022-10-31 2025-09-10 Oakwood Laboratories, LLC Mixed release profile polymer microsphere formulations comprising octreotide and methods for making and using the same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720859B2 (ja) * 1985-02-07 1995-03-08 武田薬品工業株式会社 マイクロカプセルの製造法
US6902743B1 (en) * 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US5945126A (en) 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US6270802B1 (en) 1998-10-28 2001-08-07 Oakwood Laboratories L.L.C. Method and apparatus for formulating microspheres and microcapsules
US6291013B1 (en) * 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
AU6510400A (en) 1999-08-04 2001-03-05 Oakwood Laboratories L.L.C. Slow release microspheres
US6479007B1 (en) 1999-09-16 2002-11-12 University Technology Corporation Apparatus and method for controlling pore size in polymeric membranes and thin films
KR100392501B1 (ko) 2000-06-28 2003-07-22 동국제약 주식회사 다중 에멀젼법에 의한 서방출성 미립구의 제조방법
EP1387671A1 (en) * 2001-05-03 2004-02-11 MASSACHUSETTS EYE & EAR INFIRMARY Implantable drug delivery device and use thereof
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
WO2005107714A2 (en) 2004-05-05 2005-11-17 Alkermes Controlled Therapeutics, Inc. Method of forming microparticles that include a bisphosphonate and a polymer
KR101271263B1 (ko) 2005-09-28 2013-06-07 아우리스 메디칼 아게 내이 장애 치료용 약학 조성물
CA2635374C (en) 2006-01-11 2015-12-08 Hyperbranch Medical Technology, Inc. Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
US20070292521A1 (en) * 2006-06-20 2007-12-20 Schwitzer Co., Ltd Oral Encapsulated Preparation for Aquatic Animals
US20110027331A1 (en) 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
WO2013119183A1 (en) 2012-02-06 2013-08-15 Nanyang Technological University Methods of manufacturing core-shell microparticles, and microparticles formed thereof
WO2013138322A1 (en) * 2012-03-12 2013-09-19 Janssen Pharmaceutica Nv Esketamine for the treatment of treatment-refractory or treatment-resistant depression
WO2017075136A1 (en) 2015-10-27 2017-05-04 Purdue Research Foundation Polymer-based therapeutics for inductive browning of fat
SG11202001206YA (en) 2017-09-14 2020-03-30 Agency Science Tech & Res Emulsions, methods and uses thereof
KR20240011237A (ko) 2017-12-22 2024-01-25 얀센 파마슈티카 엔브이 우울증 치료를 위한 에스케타민
EP3968979A4 (en) 2019-05-15 2023-03-01 Bexson Biomedical, Inc. KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
EP3993898B1 (en) 2019-07-01 2025-10-15 Oakwood Laboratories, Llc System and method for making microspheres and emulsions
US20220401366A1 (en) * 2019-11-15 2022-12-22 Consegna Pharma, Inc. Long acting nmda antagonists
PH12022550775A1 (en) 2019-12-20 2023-08-23 Alar Pharmaceuticals Inc Long-acting injectable formulations of ketamine pamoate salts
US20210361578A1 (en) 2020-04-03 2021-11-25 University Of Iowa Research Foundation Mek1/2 inhibitor-loaded microparticle formulation

Similar Documents

Publication Publication Date Title
AU2018271381B2 (en) Method for preparing biodegradable microsphere with improved safety and storage stability
JP6678571B2 (ja) 高薬物含有ブプレノルフィンマイクロスフェア及びその製造方法
JP3641418B2 (ja) 多重エマルジョン法による徐放出性微粒球の製造方法
RU2018100114A (ru) Кортикостероиды для лечения суставной боли
JP2023538901A5 (https=)
JP2007532640A5 (https=)
JP2016513721A5 (https=)
US20240293427A1 (en) Pharmaceutical kit for parenteral co-administration
JP2011503213A5 (https=)
CN101467959A (zh) 持续释放组合物及其制备方法
JP2015522534A5 (https=)
US20190380967A1 (en) Preparation of microparticles of an active ingredient
JP6249584B2 (ja) 薬物含有徐放性微粒子の製造方法
KR101307729B1 (ko) 초기 약물 방출이 감소된 고분자 미립자를 포함하는 주사용 조성물 및 이의 제조방법
CN105411996A (zh) 一种聚乳酸基载药控释材料的制备方法
CN115942935B (zh) 包括氯胺酮的微球制剂及其制备和使用方法
AU2022394933A1 (en) Sustained-release injectable composition containing naltrexone and method for preparing same
Liao et al. Effect of polymer terminal groups on the drug release and experimental characterization of an electrospun naringin-loaded microsphere/sucrose acetate isobutyrate (SAIB) depot
CN102846556A (zh) 一种5-氟尿嘧啶载药微球及其制备方法
ES3061392T3 (en) Microsphere formulations comprising ketamine and methods for making and using the same
RU2021112027A (ru) Инъекционные композиции микрочастиц налтрексона длительного действия
CN116617357A (zh) 包含地洛瑞林的缓释型注射用组合物及其制备方法
WO2018217840A1 (en) Method and compounds for treating peripheral neuropathy
CN118660695A (zh) 用于肠胃外联合施用的药物试剂盒
JP2026507990A (ja) オクトレオチドを含む混合放出プロファイルポリマーミクロスフェア製剤ならびにその製造方法及び使用方法